Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Arai

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Antiviral Research|June 13, 2025
Molecular mechanisms of hepatitis B virus entry inhibition by a bile acid derivative INT-767 binding to the preS1 regionAkinori Okumura, Yukiko Muraki, Jun Arai, et al.
Anticancer Research|May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10Yumi Otoyama, Jun Arai, Kaku Goto, et al.
BMC Cancer|April 21, 2022
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancerJun Arai, Yumi Otoyama, Ken-Ichi Fujita, et al.
Health Science Reports|July 21, 2020
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort studyJun Arai, Takayoshi Ito, Yuu Shimozuma, et al.
BMC Gastroenterology|November 16, 2019
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reportsJun Arai, Yuu Shimozuma, Yumi Otoyama, et al.
In Vivo (Athens, Greece)|July 2, 2020
Laparoscopic Treatment of a Hepatoduodenal Ligament Schwannoma With Infrared Indocyanine Green FluorescenceKodai Tomioka, Takeshi Aoki, Tomotake Koizumi, et al.
Medicine|June 11, 2021
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapyYuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|February 28, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 InhibitorsKeita Ogawa, Tetsuhiro Chiba, Masato Nakamura, et al.
Arquivos Brasileiros De Cardiologia|April 7, 2011
[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia], , , et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Antiviral Research|June 13, 2025
Molecular mechanisms of hepatitis B virus entry inhibition by a bile acid derivative INT-767 binding to the preS1 regionAkinori Okumura, Yukiko Muraki, Jun Arai, et al.
Anticancer Research|May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10Yumi Otoyama, Jun Arai, Kaku Goto, et al.
BMC Cancer|April 21, 2022
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancerJun Arai, Yumi Otoyama, Ken-Ichi Fujita, et al.
Health Science Reports|July 21, 2020
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort studyJun Arai, Takayoshi Ito, Yuu Shimozuma, et al.
BMC Gastroenterology|November 16, 2019
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reportsJun Arai, Yuu Shimozuma, Yumi Otoyama, et al.
In Vivo (Athens, Greece)|July 2, 2020
Laparoscopic Treatment of a Hepatoduodenal Ligament Schwannoma With Infrared Indocyanine Green FluorescenceKodai Tomioka, Takeshi Aoki, Tomotake Koizumi, et al.
Medicine|June 11, 2021
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapyYuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|February 28, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 InhibitorsKeita Ogawa, Tetsuhiro Chiba, Masato Nakamura, et al.
Arquivos Brasileiros De Cardiologia|April 7, 2011
[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia], , , et al.
Pageof 9